Molecular Diagnostics Market Forecast and Segments, 2016-2026
Molecular diagnostics is a method of analyzing and identifying the biological markers in the genome and proteome in order to identify gene expression by applying molecular biology. Molecular diagnostics are used to diagnose disease and risk involved.
Molecular diagnostics is a method of analyzing and identifying the biological markers in the genome and proteome in order to identify gene expression by applying molecular biology. Molecular diagnostics are used to diagnose disease and risk involved.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Molecular</strong><br />
<strong>Diagnostics</strong><br />
<strong>Market</strong><br />
Share, Global Trends,<br />
Analysis, Research, Report,<br />
Opportunities,<br />
Segmentation <strong>and</strong> <strong>Forecast</strong>,<br />
<strong>2016</strong>– <strong>2026</strong><br />
Future <strong>Market</strong> Insights<br />
www.futuremarketinsights.com<br />
sales@futuremarketinsights.com
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom research reports, <strong>and</strong> consulting<br />
services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes,<br />
technology inputs, valuable growth insights, aerial view of the competitive framework, <strong>and</strong> future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC, ASEAN, <strong>and</strong> BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology, Healthcare, <strong>and</strong><br />
Retail.<br />
We have a global presence with delivery centers across India specializing in providing global research reports <strong>and</strong> country<br />
research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We<br />
combine our knowledge <strong>and</strong> learning from every corner of the world to distill it to one thing – the perfect solution for our<br />
client.<br />
Research<br />
Sector Coverage<br />
Capabilities<br />
• Customized Research<br />
• Syndicated Research<br />
• Investment Research<br />
• Social Media Research<br />
• Automotive <strong>and</strong> Transportation<br />
• Chemicals & Materials<br />
• Electronics, Semiconductor, <strong>and</strong> ICT • Food <strong>and</strong> Beverages<br />
• Retail <strong>and</strong> Consumer Products<br />
• Services <strong>and</strong> Utilities<br />
• Industrial Automation <strong>and</strong> Equipment • Energy, Mining, Oil, <strong>and</strong><br />
• Healthcare, Pharmaceuticals & Medical Devices Gas<br />
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Information<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com
Report Description<br />
<strong>Molecular</strong> diagnostics is a method of analyzing <strong>and</strong> identifying the biological markers in the<br />
genome <strong>and</strong> proteome in order to identify gene expression by applying molecular biology.<br />
<strong>Molecular</strong> diagnostics are used to diagnose disease <strong>and</strong> risk involved. <strong>Molecular</strong> <strong>Diagnostics</strong><br />
helps to decide the therapies are suitable for individual patients. The new advanced<br />
technologies has qualified the instruments in providing accurate results. This ability of the<br />
diagnostic tool resulted in increased rate of acceptance of the molecular diagnostics. The<br />
concept of personalized medicine has emerged out of molecular diagnostics.<br />
<strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>: Drivers & Restraints<br />
The factors driving molecular diagnostic market are increase in dem<strong>and</strong> for care facilities,<br />
favorable regulatory policies which aims at promoting the care diagnosis, acceptance of<br />
personalized medicine, development in biomarkers, advancements in proteomics, increasing<br />
awareness of the diagnostic procedures. However rising cost of molecular diagnostics, obligation<br />
of skilled labors to h<strong>and</strong>le the complexity of instruments are the factors restraining the growth<br />
of molecular diagnostics market.<br />
<strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>: Segmentation<br />
<strong>Molecular</strong> diagnostic market is classified on the basis of product, technology, application, end<br />
use <strong>and</strong> geography.
Report Description<br />
Based on product, the global molecular diagnostic market is segmented into the following:<br />
• Instruments<br />
• Reagents<br />
• Others (service <strong>and</strong> software)<br />
Based on technology, the global molecular diagnostic market is segmented into the following:<br />
• DNA sequencing<br />
• Polymerase chain reaction<br />
• Isothermal Nucleic Acid Amplification Technology<br />
• Transcription Mediated Amplification (TMA)<br />
• In situ hybridization<br />
• Sequencing<br />
• Microarrays<br />
• Mass spectrometry<br />
• DNA sequencing<br />
• Others (southern blotting, northern blotting, electrophoresis)<br />
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-<br />
1262<br />
Based on application, the global molecular diagnostic market is segmented into following:
Report Description<br />
• Cancer<br />
• Pharmacogenomics<br />
• Genetic testing<br />
• Infectious disease<br />
• Prenatal<br />
• Neurological disease<br />
• Cardiovascular disease<br />
Based on end use, the global molecular diagnostic market is segmented into following:<br />
• Diagnostic laboratories<br />
• Hospitals<br />
• Others( nursing home, blood banks, point of care)<br />
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1262<br />
<strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>: Overview<br />
The awareness of diagnosis is giving rise to the trend of self-care management. The early<br />
diagnosis of disease or disorder helps the patient in getting better treatment <strong>and</strong> cure.<br />
Infectious disease <strong>and</strong> Oncology is estimated to be the fastest growing application owing to the<br />
increased prevalence of cancer <strong>and</strong> dem<strong>and</strong> for early diagnosis.
Report Description<br />
The introduction to specific biomarkers for the treatment has a positive impact over the<br />
molecular diagnosis market. However maximum use of reagents is estimated owing to their<br />
accurate results. Commonly used reagents are salts, formamide, sodium dodecyl sulfate <strong>and</strong><br />
dextran sulphate heparin. Growing awareness about the prenatal genetic testing for early<br />
detection of chromosomal abnormalities during pregnancy has enhanced the use of molecular<br />
diagnostics.<br />
<strong>Molecular</strong> <strong>Diagnostics</strong> <strong>Market</strong>: Region-wise Outlook<br />
Depending on geographic regions, the Global <strong>Molecular</strong> <strong>Diagnostics</strong> market is segmented into<br />
seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific<br />
Excluding Japan, Japan, <strong>and</strong> Middle East & Africa. North America is estimated to be the largest<br />
player in molecular diagnostic market owing to the technological advancements <strong>and</strong><br />
innovations, increase in R&D investments by large pharmaceutical <strong>and</strong> biotechnological<br />
industries <strong>and</strong> dem<strong>and</strong> for early diagnosis. Asia Pacific is estimated in rising molecular diagnostic<br />
market due to increase in the prevalence of diseases such as cardiovascular diseases, infectious<br />
diseases <strong>and</strong> large population suffering from diabetes.
Report Description<br />
<strong>Molecular</strong> diagnostics <strong>Market</strong>: Key Players<br />
Some of the key players identified in the molecular diagnostic market are Abbott laboratories,<br />
Becton Dickinson, Novartis, Roche <strong>Diagnostics</strong>, Johnson <strong>and</strong> Johnson, Bio-Rad Laboratories,<br />
bioMerieux, Danaher Corporation, Qiagen N.V, Siemens Healthcare, Cepheid, Hologic, Inc,.
Thank You!<br />
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
For other queries contact:<br />
Future <strong>Market</strong> Insights: 616 Corporate Way, Suite 2-9018,<br />
Valley Cottage, NY 10989, United States<br />
T: +1-347-918-3531 | D: +1-845-579-5705
Change language